The core function of the Screening Group (SCR) at IARC is to provide data on the accuracy, reproducibility, efficacy, benefits, harmful effects, and cost-effectiveness of various early detection interventions for breast, cervical, colorectal, and oral cancers, among others, in reducing deaths and improving patients’ quality of life in various settings. These data can then be used to inform and improve the rational use of health-care resources. The Group’s ultimate objective is to guide the development of public health policies for implementing screening in a variety of health-care settings, in particular in low- and middle-income countries (LMICs).
SCR conducts field studies in LMICs to evaluate various early detection methods for breast, cervical, colorectal, and oral cancer control. These initiatives also address the means by which screening services could be scaled up through local public health services. SCR develops various training resources to catalyse and augment capacity building in close collaboration with national institutions and government health services. Through its research programme, SCR generates scientific evidence to support the development of resource-appropriate early detection policies and health systems for the delivery of effective early services. The Cancer Screening in 5 Continents (CanScreen5) project of the Group aims to collect information on characteristics and performance of cancer screening programmes around the world and disseminate such information for informed decision making in cancer screening programmes. For example, the Group significantly contributed also to the evaluation of the safety and efficacy of less than three doses of the HPV vaccine in protecting against cervical cancer.
Conference: Second Joint Breast Cancer & Gynecology Malignancy, Doha, Qatar18/10/2019 – 19/10/2019
Dr Andre Carvalho attended this conference, organized by the Qatar Health Department and discussed of breast cancer prevention and lifestyle modification.
International symposium on cancer research, Shanghai, China17/10/2019 – 19/10/2019
Dr Sauvaget participated to the Sino-French Symposium on cancer organized by the Jia Tong University and CLARA, and the ceremony of signature of the MoU between IARC and Jiao Tong University, Shanghai.
More detail about this meeting.
World Endoscopy Organization Colorectal Cancer (CRC) Screening Committee Meeting, Barcelona, Spain18/10/2019
Mr Eric Lucas presented the new initiative from IARC, Cancer Screening in 5 continents (CanScreen5) during the WEO screening committee meeting. The CanScreen5 project aims to collect information on characteristics and performance of cancer screening programmes around the world and disseminate such information for informed decision making in cancer screening programmes.
Visit the CanScreen5 website.
|Basu P., Hutubessy R., Broutet N. Cervical cancer: WHO called for elimination, not eradication. BMJ. 2019 Sep 26;366:l5668.|
|Ndizeye Z., Menon S., Van Geertruyden J.P., Sauvaget C., Jacquemyn Y., Bogers J.P., Benoy I., Vanden Broeck D. Performance of OncoE6TM Cervical Test in detecting cervical precancer lesions in HIV-positive women attending an HIV clinic in Bujumbura, Burundi: a cross-sectional study. BMJ Open. 2019 Sep 6;9(9):e029088.|
|Vale D.B., Anttila A., Ponti A., Senore C., Sankaranarayanan R., Ronco G., Segnan N., Tomatis M., Žakelj M.P., Elfstrom K.M., Lonnberg S., Dillner J., Basu P. Response to the author: invitation to cancer screening: putting the car before the horse? Eur J Cancer Prev. 2019 Sep;28(5):458-459.|